The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.
By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...
(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...
In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field ...
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
The Kansas Supreme Court is weighing whether to block a sweeping state law that lets workers easily bypass COVID-19 vaccine ...
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback